- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Biota Pharmaceuticals Inc+ Add to Watchlist
NB1:GR1.806 EUR 0.021 1.15%
As of 04:43:23 ET on 12/29/2014.
Company Profile for Biota Pharmaceuticals Inc (NB1)
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Biota Pharmaceuticals Inc
Key Executives for Biota Pharmaceuticals Inc (NB1)
|Russell H PlumbChairman||Peter AzzarelloChief Accounting Officer|
|Joseph M PattiPresident/CEO|